Tirzepatide

Switching from Zepbound to compounded tirzepatide is clinically simple when the compounded product uses tirzepatide base API at accurate potency.

Introduction Switching from Mounjaro® to compounded tirzepatide works clinically when the compounded product uses tirzepatide base API and the dose conversion is handled carefully….

The honest answer is the same one you get for compounded semaglutide: it depends almost entirely on the pharmacy.

The short answer: yes, when the compounded product contains the same dose of the same molecule at the same purity. Tirzepatide is tirzepatide.

Yes. Compounded tirzepatide is available in 2026, dispensed by state-licensed 503A pharmacies on patient-specific prescriptions.

Compounded tirzepatide is available through 503A pharmacies in 2026 when prescribed for an individual patient with documented clinical need.

Zepbound is Eli Lilly’s FDA-approved tirzepatide for chronic weight management, approved November 2023 at doses up to 15 mg weekly.

Mounjaro is Eli Lilly’s brand-name tirzepatide, FDA-approved in May 2022 for type 2 diabetes.

Switching between Mounjaro, Zepbound, and compounded tirzepatide is straightforward because the active ingredient is identical.